News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Seven new DNA regions linked to kidney cancer risk
Researchers have found seven new single-letter changes to DNA that are linked to an increased chance of developing renal cell carcinoma.
New three-in-one blood test opens door to precision medicine for prostate cancer
Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes.
Better treatment for high-risk children’s cancer shown in major trial
Children with a high-risk, deadly form of neuroblastoma will benefit from a treatment regime that improves survival and reduces side-effects, following the publication of a major European trial.
Genetic testing can pick out men at increased risk of testicular cancer
Testing for large numbers of genetic changes can identify men with over a 10-fold increased risk of testicular cancer, a new study shows.
New chemotherapy approach offers breast cancer patients a better quality of life
Using a different chemotherapy drug to prevent the return of breast cancer is just as effective as the current standard approach and crucially means a better quality of life, according to a new clinical trial.
ASCO 2017: Adding abiraterone to standard treatment improves prostate cancer survival by almost 40%
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37%, according to the results of one of the largest-ever clinical trials for prostate cancer.
-content.tmb-hbmobile.jpg?Culture=en&sfvrsn=fec93f9d_2 "Dispensing medicines for a clinical trial (Jan Chlebik for the ICR, 2014) content")
ASCO 2017: Ovarian cancer drug delivers ‘very promising’ results in early trial
A new targeted treatment for ovarian cancer has shown ‘very promising’ results in an early clinical trial – shrinking tumours in half of women with the disease.
Pioneering genetic research into myeloma is spearheading our search for new treatments
Our researchers are pioneering a new understanding of the genetic complexities of myeloma and the innovative use of existing drugs as treatments, as Conor McKeever finds out.
New genetic cause of kidney cancer in children discovered
Scientists have identified a new genetic cause of a childhood kidney cancer called Wilms tumour – revealing insights into how loss of control of chromosome number can lead to cancer.
New benchmarking resource for tricky type of gene mutation
Researchers have made available a vital resource that will allow labs throughout the world to assess how accurately they are detecting an important type of mutation.
Study suggests new approach to assess patients’ cancer genetics
Scientists have used mathematics to predict how many biopsy samples need to be taken from a patient to give an accurate picture of the genetic make-up of their cancer.
‘Free-breathing’ MRI scan is accurate enough for clinical trials
A magnetic resonance imaging (MRI) technique that can measure tumours in the body could be an easy and reliable way to assess lung cancer’s response to treatment, a new study shows.
